Y.S.P. Southeast Asia Holding Berhad (KLSE: YSPSAH)

Market Cap	320.57M
Revenue (ttm)	361.24M
Net Income (ttm)	28.65M
Shares Out	141.84M
EPS (ttm)	0.20
PE Ratio	11.19
Forward PE	n/a
Dividend	0.11 (4.91%)
Ex-Dividend Date	Jun 24, 2024

Volume	17,300
Average Volume	63,710
Open	2.240
Previous Close	2.200
Day's Range	2.200 - 2.240
52-Week Range	2.180 - 3.180
Beta	0.23
RSI	44.05
Earnings Date	Feb 26, 2025

About KLSE: YSPSAH

Y.S.P. Southeast Asia Holding Berhad, together with its subsidiaries, manufactures and trades in generic drugs. The company operates through three segments: Manufacturing, Trading, and Investment Holding. It manufactures, sells, imports, exports, trades in, and distributes pharmaceutical and veterinary products, pharmaceutical fine chemicals, raw material, health food products, and medical devices. The company also manufactures aquatic, cosmetic, and biotechnology products, as well as traditional herbal medicines, food supplements, over-the-cou...

• Industry: Pharmaceutical Preparations
• Founded: 1987
• Employees: 1,369
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: YSPSAH

Financial Performance

In 2023, YSPSAH's revenue was 355.00 million, an increase of 6.21% compared to the previous year's 334.25 million. Earnings were 37.32 million, an increase of 8.27%.